Literature DB >> 25696570

Open access echocardiography is feasible in the Netherlands.

L H B Baur, L Veenstra, T Lenderink, C L B Lodewijks-van der Bolt, R A G Winkens, F L M Soomers, H E J H Stoffers.   

Abstract

OBJECTIVES: In an urban region in the Netherlands, general practitioners (GPs) were offered an open access echocardiographic service. We report the outcomes of the first two years of this project.
METHODS: GPs were given a course on the indications and restrictions for diagnostic referral as well as the interpretation of echocardiographic results. Indications were restricted to `dyspnoea', `cardiac murmur' and `peripheral oedema'. A uniform request form was developed, using ticking boxes for quick completion. The echocardiogram was performed within one week after the request. Results were interpreted by the cardiologist according to the criteria of the Dutch, European and American Societies of Echocardiography.
RESULTS: Sixty GPs from 43 general practices participated, covering a practice population of 130,000 persons. During a period of 24 months, 198 patients were referred. Only 1.5% of the workload of the echocardiography department was due to requests from GPs. The GPs kept well to the agreements on indications for echocardiography (91% approved reasons). An abnormal echocardiographic outcome was found in 53% of all patients. For `cardiac murmur' this was 52%, for `dyspnoea' 63%, and for `peripheral oedema' 58%. Left ventricular dysfunction was present in 49 patients (25%); diastolic dysfunction was present in most of them (39 patients, 19%). Systolic dysfunction (LVEF < 40%) was found in 19 patients (10%). Twenty patients (10%) appeared to have relevant aortic or mitral valve disease.
CONCLUSION: GPs did not overuse the open access echocardiographic service; they possibly used it conservatively. To prevent underdiagnosis of left ventricular dysfunction, diagnostic strategies in which electrocardiogram, NT-pro-BNP and echocardiography are combined, should be developed.

Entities:  

Keywords:  diagnostic imaging; heart failure; open access echocardiography; valvular disease

Year:  2006        PMID: 25696570      PMCID: PMC2557303     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  28 in total

Review 1.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

Review 2.  Systematic review of open access echocardiography for primary care.

Authors:  Kamlesh Khunti
Journal:  Eur J Heart Fail       Date:  2004-01       Impact factor: 15.534

3.  Regional differences in cardiovascular risk factor profile cannot fully explain differences in cardiovascular morbidity in the Netherlands: a comparison of two urban areas.

Authors:  A W Plat; M J M te Wierik; A A Kroon; H J A Schouten; M van den Akker; C P van Schayck; P W de Leeuw; K-J Hajema; H E J H Stoffers
Journal:  Neth J Med       Date:  2005-09       Impact factor: 1.422

4.  Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantitation, and physiologic variability in clinical and investigational applications.

Authors:  H F Kuecherer; L L Kee; G Modin; M D Cheitlin; N B Schiller
Journal:  J Am Soc Echocardiogr       Date:  1991 May-Jun       Impact factor: 5.251

5.  Prevalence of normal resting left ventricular function with normal rest electrocardiograms.

Authors:  T F Christian; T D Miller; P Chareonthaitawee; D O Hodge; M K O'Connor; R J Gibbons
Journal:  Am J Cardiol       Date:  1997-05-01       Impact factor: 2.778

6.  Open-access echocardiography to general practitioners for suspected heart failure.

Authors:  J J Murphy; J P Frain; P Ramesh; R N Siddiqui; C M Bossingham
Journal:  Br J Gen Pract       Date:  1996-08       Impact factor: 5.386

7.  Open access echocardiography: a prospective audit of referral patterns from primary care.

Authors:  S G Williams; P Currie; J H Silas
Journal:  Int J Clin Pract       Date:  2003-03       Impact factor: 2.503

8.  The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction- cost-effectiveness in relation to open access echocardiography.

Authors:  Victor Sim; David Hampton; Ceri Phillips; Su-Neng Lo; Sanjeev Vasishta; John Davies; Micheal Penney
Journal:  Fam Pract       Date:  2003-10       Impact factor: 2.267

9.  Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography?

Authors:  A R Houghton; N J Sparrow; E Toms; A J Cowley
Journal:  Int J Cardiol       Date:  1997-10-31       Impact factor: 4.164

Review 10.  B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians.

Authors:  Roberto Cardarelli; Tomas G Lumicao
Journal:  J Am Board Fam Pract       Date:  2003 Jul-Aug
View more
  4 in total

1.  Age is an independent risk factor for left atrial dysfunction: results from an observational study.

Authors:  M A M Ploumen; L H B Baur; M J Streppel; C L B Lodewijks-van der Bolt; B Winkens; R A G Winkens; H E J H Stoffers
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

2.  Open access echocardiography: should we proceed?

Authors:  E P de Kluiver; M J de Boer
Journal:  Neth Heart J       Date:  2006-11       Impact factor: 2.380

3.  Evaluation of an open access echocardiography service in the Netherlands: a mixed methods study of indications, outcomes, patient management and trends.

Authors:  Leanne M S G van Heur; Leo H B Baur; Marleen Tent; Cara L B Lodewijks-van der Bolt; Marjolijn Streppel; Ron A G Winkens; Henri E J H Stoffers
Journal:  BMC Health Serv Res       Date:  2010-02-10       Impact factor: 2.655

4.  Benefits of an open access echocardiography service: a Dutch prospective cohort study.

Authors:  N van Gurp; L J M Boonman-De Winter; D W Meijer Timmerman Thijssen; H E J H Stoffers
Journal:  Neth Heart J       Date:  2013-09       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.